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ABSTRACT
The N-terminal domain of the coronavirus nucleo-
capsid (N) protein adopts a fold resembling a right
hand with a flexible, positively charged b-hairpin
and a hydrophobic palm. This domain was shown
to interact with the genomic RNA for coronavirus
infectious bronchitis virus (IBV) and severe acute
respiratory syndrome coronavirus (SARS-CoV).
Based on its 3D structure, we used site-directed
mutagenesis to identify residues essential for the
RNA-binding activity of the IBV N protein and viral
infectivity. Alanine substitution of either Arg-76 or
Tyr-94 in the N-terminal domain of IBV N protein led
to a significant decrease in its RNA-binding activity
and a total loss of the infectivity of the viral RNA
to Vero cells. In contrast, mutation of amino acid
Gln-74 to an alanine, which does not affect the
binding activity of the N-terminal domain, showed
minimal, if any, detrimental effect on the infectivity
of IBV. This study thus identifies residues critical
for RNA binding on the nucleocapsid surface, and
presents biochemical and genetic evidence that
directly links the RNA binding capacity of the
coronavirus N protein to the viral infectivity in
cultured cells. This information would be useful
in development of preventive and treatment
approaches against coronavirus infection.
INTRODUCTION
RNA viruses, including coronaviruses, encode a group of
structural phosphoproteins with basic patches on their sur-
face. As a pivotal structural component of the virion, this
group of proteins plays essential roles in packaging the
RNA genome to form a ribonucleoprotein (RNP) complex
resulting from assembly of the viral RNA and multiple copies
of the (nucleo)capsid protein. A detailed dissection and
characterization of the intrinsic RNA-binding properties of
these proteins are thus essential for understanding several
important processes in the life cycle of RNA viruses, includ-
ing assembly of the nucleocapsid, the speciﬁc encapsidation
of viral RNA and morphogenesis of virions. In this study,
amino acid residues in the N-terminal domain of the nucleo-
capsid (N) protein of a coronavirus that are critical for its
RNA-binding activity are identiﬁed and their roles in viral
infectivity are analyzed, using site-directed mutagenesis
based on our previous structural studies.
Coronaviruses are enveloped viruses containing the largest
known single-stranded, positive-sense RNA genome of
 30 kb (1). During the coronavirus life cycle, the N protein
is synthesized in large amounts and is thought to play an
important role by speciﬁcally packaging the viral genome
into a ﬁlamentous nucleocapsid of  10 to 15 nm in diameter
and several 100 nm in length, a macromolecular structure that
is visible by using electron microscopy (2). In addition to its
structural role, the N protein also participates in viral RNA
transcription, replication and in modulating the metabolism
of host cells (3–13). Using X-ray crystallography techniques,
we recently determined a 3D structure of the N protein from
coronavirus infectious bronchitis virus (IBV), a prototype
coronavirus, and showed that the basic building block for
nucleocapsid assembly was a dimer of the N protein (14).
The 409 amino acids long IBV N protein is composed of
two globular domains that are resistant to proteolysis.
Amino acids 29 to 160 form the N-terminal RNA binding
domain and residues 218 to 329 form its C-terminal dimeri-
zation domain (5,14). Even though the structure of the
N-terminal domain was determined in the absence of a
nucleic acid ligand, its overall shape and the distribution of
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binding. The outer surface of the N-terminal domain is
enriched in aromatic and basic residues, a common feature
for RNA-binding proteins (15). The shape of this domain is
reminiscent of a hand having basic ﬁngers, a hydrophobic
palm and an acidic ‘wrist’. The positively charged ‘ﬁngers-
like’ b-hairpin extension could neutralize the phosphate
groups emanating from RNA, whilst the base moieties
could make contact with exposed aromatic residues from
the hydrophobic palm (14).
Based on this structural hypothesis, we chose to mutate
a number of evolutionarily conserved residues in the
N-terminal domain of the IBV N protein in order to assess
their roles in viral genomic RNA binding and in viral
replication. We used puriﬁed recombinant wild type and
mutant proteins containing the N-terminal domain expressed
in Escherichia coli for RNA binding assays. These studies
led to the identiﬁcation of a number of amino acid
residues essential for the RNA-binding activity of the domain.
Subsequently, we introduced mutations that either severely or
mildly impair the RNA binding activities of the N-terminal
domain into an infectious cDNA clone system derived
from the genomic RNA of IBV to assess their effects on viral
replication and infectivity. We identiﬁed several residues
exposed to the solvent whose substitutions to alanine yield a
decrease of RNA binding and a concomitant reduction in
virus replication. Interestingly, residues Arg-76 and Tyr-94,
located at the base of the positively charged ﬂexible hairpin
loop and on the hydrophobic platform, respectively, were crit-
ical for RNA binding and viral infectivity.
MATERIALS AND METHODS
Expression and purification of IBV N protein
His-taggedwildtypeandmutantN-terminaldomainsofIBVN
proteinwereexpressedinE.coliBL-21byinductionwith1mM
isopropyl-b-D-thiogalactopyranoside (IPTG). Cells were lysed
by sonication and puriﬁed by metal afﬁnity chromatography
with Protino-Ni 150 kit (Macherey Nagel).
Synthesis of RNA probes
PCR fragments covering the IBV genome from 27100 to
27608 nt were cloned into a plasmid in either forward or
reverse orientation under the control of a T7 promoter. The
Dig-labeled sense (+) and anti-sense ( ) RNA probes were
made in vitro using the DIG RNA labeling kit according to
the instructions of the manufacturer (Roche).
Northwestern blot
FivemicrogramsofpuriﬁedproteinswereresolvedonanSDS-
15% polyacrylamide gel and transferred onto nitrocellulose
membranes (Hybond C-Extra, Amersham Biosciences) using
a semi-dry transfer apparatus. Membranes were washed for
10 min with the probe buffer [1· Denhardt’s Reagent, 1 mM
EDTA, 10 mM Tris–HCl (pH 7.5) and 50 mM NaCl], blocked
for 1 h with 25 mg/ml yeast tRNA (Ambion) and subsequently
incubated with 10 mg of DIG-labeled RNA probe in the same
probe buffer for 1 h. Membranes were washed three times
for 15 min each with the probe buffer, before proceeding to
detection with CDP-Star (Roche) according to the manufac-
turer’s instructions.
Construction of an infectious IBV clone, introduction of
mutations into the clones and rescue of recombinant
viruses
Construction of an infectious IBV clone was carried out essen-
tially as described (16,17). Brieﬂy, ﬁve fragments spanning the
entire IBV genome were obtained by RT–PCR from Vero cells
infected with the Vero cell-adapted IBV p65. The PCR products
were puriﬁed from agarose gels and cloned into pCR-XL-TOPO
(Invitrogen) or pGEM-T Easy (Promega) vectors. Subsequently,
fragment A was removed from pCR-XL-TOPO by digestion
withNheIandEcoRI,and subclonedinto pKT0vector. Plasmids
were digested with either BsmBI (fragment A) or BsaI (frag-
ments B, C, D and E). The digested plasmids were separated
on 0.8% agarose gels containing crystal violet. Bands corres-
pondingtoeachofthefragmentswerecutfromthegelsandpuri-
ﬁedwithQIAquickgelextractionkit(QIAGENInc.).Fragments
A and B, and fragments C, D and E were ﬁrst ligated with T4
DNA ligase at 4 C overnight. The two reaction mixtures were
then mixed and further ligated at 4 C overnight. The ﬁnal liga-
tion products were extracted with phenol/chloroform/isoamyl
alcohol (25:24:1), precipitated with ethanol and detected by
electrophoresis on 0.4% agarose gels.
Full-length transcripts were generated in vitro using
the mMessage mMachine T7 kit (Ambion, Austin, TX). The
N transcripts were generated by using a linearized pKT0-
IBVN containing IBV N gene and the 30-untranslated region
(30-UTR) as templates. The in vitro synthesized full-length
and N transcripts were treated with DNase I and puriﬁed with
phenol/chloroform. Vero cells were grown to 90% conﬂuence,
trypsinized, washed twice with cold phosphate-buffered saline
(PBS),andresuspendedinPBS.RNAtranscriptswereaddedto
400 ml of Vero cell suspension in an electroporation cuvette,
and electroporated with one pulse at 450 V, 50 mF with a
Bio-Rad Gene Pulser II electroporator. The transfected Vero
cells were cultured overnight in 1% FBS-containing MEM
in a 60 mm dish or a 6-well plate and further cultured in
MEM without FBS.
Mutations were introduced into the corresponding frag-
ments by using QuickChange site-directed mutagenesis kit
(Stratagene), and conﬁrmed by sequencing of the whole frag-
ments.
Growth curve and plaque sizes of the recombinant
viruses on Vero cells
Conﬂuent monolayers of Vero cells on 6-well plates were
infected with wild-type and mutant viruses at a multiplicity
of  1 PFU/cell. After 1 h of incubation at 37 C, cells were
washed twice with PBS and cultured in 3 ml of MEM con-
taining 0.5% carboxymethy cellulose for 3 days. The cells
were ﬁxed and stained with 0.1% toluidine.
Vero cells were infected with wild-type and recom-
binant IBV, and harvested at different times post-infection.
Viral stocks were prepared by freezing/thawing of the cells
three times. The plaque-forming units per ml of each
sample were determined by infecting Vero cells on 6-well
plates in duplicate with 10-fold serial dilution of each viral
stock.
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Vero cells were infected with wild type and Q74A mutant
virus at a multiplicity of  1 PFU/cell. Total RNA was
extracted from cells infected with wild type or mutant vir-
uses. Ten micrograms of RNA were added to a mixture of
1· MOPS, 37% formaldehyde and formamide and incubated
at 65 C for 20 min before subjected to gel electrophoresis.
The segregated RNA bands were transferred onto a
Hybond N+ membrane (Amersham Biosciences) via capillary
action overnight and ﬁxed by ultraviolet (UV) crosslinking
(Stratalinker). Hybridization of Dig-labeled DNA probes
was carried out at 50 C in hybridization oven overnight.
Membranes were washed three times for 15 min each with
the probe buffer, before proceeding to detection with CDP-
Star (Roche) according to the manufacturer’s instructions.
Western blot analysis
Vero cells were infected with wild type and Q74A mutant
virus at a multiplicity of  1 PFU/cell. Total proteins extrac-
ted from Vero cells were lysed with 2· SDS loading buffer in
the presence of 200 mM DTT plus 10 mM of iodoacetamide
and subjected to SDS–PAGE. Proteins were transferred to
PVDF membrane (Stratagene) and blocked overnight at 4 C
in blocking buffer (5% fat free milk powder in PBST buffer).
The membrane was incubated with 1:2000 diluted primary
antibodies in blocking buffer for 2 h at room temperature.
After washing three times with PBST, the membrane was
incubated with 1:2000 diluted anti-mouse or anti-rabbit
IgG antibodies conjugated with horseradish peroxidase
(HRP) (DAKO) in blocking buffer for 1 h at room tempera-
ture. After washing three times with PBST, the polypeptides
were detected with a chemiluminescence detection kit (ECL,
Amersham Biosciences) according to the manufacturer’s
instructions.
Construction of plasmids
PCR products covering the IBV sequence from 25957–
26352 nt were ampliﬁed by using the forward primer 50-CG-
GGCATATGTCTTCTGGAAATGCATCTTGG-30 and the
reverse primer 50-CGGGATCCTTACAGGGGAATGAAGT-
CCCAAC-30. The PCR fragments were digested with NdeI
and BamHI, and ligated into NdeI- and BamHI-digested
pET-16b (Novagen). Each mutation was introduced by two-
round PCR and the mutation introduced was conﬁrmed by
automated nucleotide sequencing.
RESULTS
Overview of the structure and RNA-binding properties
of the N-terminal domain of coronavirus N protein
The N-terminal RNA-binding domain of N protein from both
IBV and SARS-CoV contains a ﬂexible and positively
charged hairpin loop that extends much beyond the protein
core and that could grasp a nucleic acid substrate by neutral-
izing its phosphate groups (Figure 1) (14,18). Positively
charged lysine and arginine residues in the N-terminal
domain of SARS-CoV N protein were proposed to bind a
32 nt stem–loop structure located at the 30 end of the
SARS-CoV RNA genome (18). Indeed, the structure of this
domain possesses some features reminiscent of RNA-binding
proteins sharing the RNP fold (19–22). These RNA-binding
proteins, including the U1A spliceosomal protein (23) and
the coat protein from MS2 bacteriophage (24), bind the
RNA ligand with residues emanating from the surface of
a four-stranded anti-parallel b sheet. Presumably, strands
b2 and b3 as well as the ﬂexible b-hairpin from the IBV
nucleocapsid protein could fulﬁll a similar role by interacting
with phosphate groups from an RNA ligand (Figure 1). The
b3 strand is the longest in the N-terminal domain of IBV N
protein and several evolutionarily conserved residues project
from it (Figure 1). Nucleotide bases in single-stranded RNA
have a tendency to stack either on adjacent bases or with
aromatic side chains of the protein (20).
Mutational analysis of amino acid residues essential
for RNA-binding in the N-terminal domain of IBV
N protein
The above structural model was partially supported by the
demonstration that the N-terminal domain of IBV N protein
could interact with RNA fragments corresponding to the
30 end of the viral genome (14). To more vigorously test
this model, systematic mutagenesis of residues essential for
the RNA-binding activity was carried out. We targeted the
exposed hydrophobic residues Tyr-92 and Tyr-94 (strand
b3) that could form stacking interactions with the nucleotide
bases as well as several basic or polar residues emanating
from the b-hairpin (Figure 2a). As summarized in
Figure 2a, 10 amino acids were mutated to alanine. These
residues are either exposed to the solvent (Gln-74, Arg-76,
Lys-78, Lys-81, Tyr-92 and Tyr-94) or have been conserved
during evolution (Tyr-70 and Arg-73) and are thus likely to
be involved in RNA binding or to play an undeﬁned func-
tional role. In addition, mutation of Asp-111 to an alanine
was included as an additional control for the RNA-binding
assay (Figure 2a).
The wild type and mutant constructs, spanning 29 to 160
amino acids with a hexa-histidine tag at their N-termini,
were cloned into a bacterial expression vector, expressed in
E.coli and puriﬁed to near homogeneity. Approximately
equal amounts of the puriﬁed proteins were separated on
SDS–PAGE (Figure 2b, upper panels). After transfer to a
Hybond C extra membrane, the RNA-binding activities of
wild type and mutant proteins were analyzed by northwestern
blot with two probes corresponding to the positive- and
negative-sense 30-UTR of IBV, respectively. A moderate
decrease in binding to both the positive and negative sense
RNA probes was consistently observed with most mutant
proteins, and representative gels are shown in Figure 2b
(Figure 2b, middle and lower panels). Among all mutants,
mutation of Tyr-94 to an alanine residue showed the most
signiﬁcant reduction in binding of the domain to both positive
and negative probes. The RNA binding activities of this
mutant to positive and negative probes were reduced to 27
and 25%, respectively, of the wild type were observed
(Figure 2b, lane 9). Relatively less reduction in the RNA-
binding activity was observed for the R76A, K78A, K81A
and Y92A mutant proteins which retain between 50–74%
of the wild-type binding activity (Figure 2b, lanes 5–8).
With the exception of the Q74A and D111A mutants,
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to both the positive- and negative-sense RNAs, (Figure 2b,
lanes 4 and 10), all other mutants showed a certain degree
of reduction in their binding activity to either RNA probes
(Figure 2b). As a control, a circular dichroism analysis of
the two corresponding R76A and Y94A single mutants was
performed to check whether the mutant proteins were prop-
erly folded. The spectra obtained for these two mutants
were similar to the wild-type protein, ruling out any drastic
conformational change introduced by the mutations (data
not shown).
As none of the single mutations introduced could totally
abrogate the RNA-binding activity of the IBV N-terminal
domain, two mutant constructs carrying double mutations
were made. As can be seen in Figure 2b (lanes 13 and 14),
mutations of both Arg-73 and Lys-78 to alanine residues
(R73/K78A) reduced the RNA-binding activities to the
positive- and negative-sense RNA probes between 44 and
10% of wild-type, respectively. Mutations of both Arg-76
and Tyr-94 (R76/Y94A) to alanine reduced the RNA-binding
to the positive- and negative-sense RNA probes to only 7 and
19% of wild-type, respectively (Figure 2b, lanes 15 and 16).
Taken together, these results are consistent with the presence
of an extended RNA binding site covering a large part of
the accessible surface of the N-terminal domain of the
coronavirus N protein. They are also in agreement with
the assumption that removal of a single positive charge at
the protein surface by mutation of a lysine or arginine residue
to an alanine is insufﬁcient to totally disrupt the formation of
the protein–RNA complex.
Introduction of single amino acid substitutions into the
IBV genome and analysis of their effects on the recovery
of infectious viruses
The R76A and Y94A mutations were ﬁrst introduced into an
infectious clone of IBV, and in vitro transcribed full-length
RNA molecules derived from wild type and mutant cons-
tructs were generated by in vitro transcription using the T7
RNA polymerase in the presence of a cap analog. Electro-
poration of wild-type RNA transcripts together with an
RNA fragment covering the N protein region into Vero
cells showed the formation of massive CPE at 2 days post-
electroporation (Figure 3, panel rIBV+N). In contrast, no
Figure 1. Structure of the N-terminal RNA binding domain of IBV N protein. (a) Structure-based alignment of coronavirus nucleocapsid amino acid sequences
corresponding to the N-terminal RNA binding domain. Secondary structure elements are labeled above the sequence for IBV-N29–160 and below for the SARS-
CoV N-terminal fragment [Huang et al. (18)]. Sequences of IBV (IBV, strain Beaudette, NP_040838); H-CoV (Human Coronavirus, strain HKU1, YP_173242);
MHV (Murine Hepatitis Virus, strain 1, AAA46439); TGEV (Porcine Transmissible Gastroenteritis Virus, strain RM4, AAG30228) and SARS (SARS-
Coronavirus, 1SSK_A) were obtained from GenBank. Conserved residues are shaded. (b) Surface representation of the IBV-N-terminal fragment with
electrostatic potentials colored in blue (positive) and red (negative). Positively charged residues in the flexible hairpin loop and aromatic residues on the
hydrophobic floor that are exposed to the solvent and which were subjected to mutagenesis in this study are labeled.
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transcripts derived from either mutant up to 5 days post-
electroporation, suggesting that no infectious virus could
be rescued from the two mutant transcripts (Figure 3,
panels R76A+N and Y94A+N). These results indicate that
R76A and Y94A mutations, which severely reduce the
RNA-binding activity of the N-terminal domain of the N
protein, may abolish the infectivity of the in vitro synthesized
full-length IBV transcripts.
Introduction of Q74A and Y92A mutations into the full-
length infectious clone of IBV was then carried out. Typical
CPEs were observed in cells transfected with Q74A mutant
transcripts at 3 days post-electroporation and recombinant
viruses were recovered (Figure 3, panel Q74A). In cells
electroporated with Y92A transcripts, a typical CPE
was observed at 2 days post-electroporation [Figure 3,
panel Y92A(1)]. Incubation of the transfected cells for one
more day saw the appearance of more CPEs [Figure 3,
panel Y92A(2)]. However, prolonged incubation of the trans-
fected cells up to 6 days saw no spread of the infection
from the two initiated infected loci to neighboring cells.
Re-infection of fresh Vero cells with either medium collected
from these cells or total cell lysates prepared by freezing and
thawing of the transfected cells showed no detection of the
CPE formation, indicating that the minute amount of
viruses rescued from the initially transfected cells could not
maintain infectivity in subsequent passage.
The R76A and Y94A mutant N constructs were then used
to test if they could facilitate the rescue of the in vitro
synthesized full-length IBV transcripts in trans. As
mentioned, efﬁcient recovery of infectious virus from the
in vitro transcribed full-length IBV RNA requires
a
b
Figure 2. Northwestern analysis of the RNA binding activity of wild-type and mutant N-terminal domain of the IBV N protein. (a) Diagram showing the alanine
mutants included in this study. (b) RNA binding assay for the various mutants of the IBV N protein N-terminal domain produced in this study. The binding
affinities of mutated IBV N protein N-terminal domains towards positive and negative RNA ligands corresponding to 26 539–27 608 nt of the IBV genome were
evaluated by northwestern blot. The mutants were separated by SDS–PAGE, transferred to Hybond C extra membrane and detected by digoxin-labelled RNA.
The relative binding affinities, which were assumed to be proportional to the intensities of the detected bands, were normalized with respect to the binding
activity of the wild-type domain, which was arbitrarily taken as 100.
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the in vitro synthesized RNA covering the N gene. Electro-
poration of wild-type full-length IBV transcripts together
with RNAs synthesized in vitro from wild-type and the two
mutant N constructs, respectively, showed efﬁcient recovery
of the infectious virus with CPE observed on almost the
whole monolayer at 3 days post-electroporation (Figure 3,
panels rIBV+N-R76A and rIBV+N-Y94A). In contrast,
cells transfected with the full-length IBV transcripts only
(without co-electroporation with the N transcripts) showed
the formation of a single CPE on the whole monolayer at
3 days post-electroporation (Figure 3, panel rIBV-N).
Analysis of negative-strand RNA replication and
subgenomic RNA transcription in cells transfected with
wild-type and mutant full-length transcripts
As no infectious virus was recovered from cells transfected
with R76A and Y94A mutant transcripts, total RNA was
extracted from cells electroporated with wild-type and mutant
full-length transcripts and RT–PCR ampliﬁcation of sub-
genomic mRNAs was carried out to check whether a low
level of RNA replication and subgenomic mRNA transcrip-
tion occurred in cells transfected with the mutant transcripts.
The forward primer used in this reaction corresponds to
the leader sequence from 26–46 nt in the genomic RNA
and the downstream primers covers IBV sequences from
24784 to 24803 nt. If transcription of subgenomic mRNAs
did occur, a 415 bp PCR product corresponding to the 50-
terminal region of the subgenomic mRNA4 and a 1010 bp
fragment corresponding to the 50-terminal region of the sub-
genomic mRNA3 would be expected. As shown in Figure 4a,
a dominant 415 bp band and a weak 1010 bp band were
observed in cells electroporated with wild-type full-length
transcripts at 2 days post-electroporation (lane 2). Sequencing
of the PCR fragments conﬁrmed that they represent the cor-
rect sequences of the corresponding regions of the subge-
nomic mRNAs 3 and 4, respectively. The same PCR
products were not detected in cells electroporated with the
R76A and Y94A mutant transcripts, respectively, at 24,
48 and 72 h post-electroporation (Figure 4a, lanes 3–8). In
cells electroporated with Q74A mutants at 3 days post-
electroporation, RT–PCR ampliﬁcation of the subgenomic
mRNA 3 and 4 showed the detection of the 415 and 1010
bp bands (Figure 4a, lane 9). The same PCR products were
not evident in cells electroporated with the Y92A mutant
transcripts (Figure 4a, lane 10).
RT–PCR ampliﬁcation of the negative strand RNA was
performed to check if RNA replication occurred in these
transfected cells. The primer pair was chosen so that the
IBV sequence from 14931 to 15600 nt would be ampliﬁed
by the RT–PCR. If replication of viral RNA occurred, a
670 bp PCR fragment would be expected. As shown in
Figure 4b, RT–PCR fragments ampliﬁed from both positive
(lanes 4, 7 and 9) and negative (lanes 3, 6 and 10) strand
RNA templates were obtained from cells transfected with
the mutant transcripts. The amount of the negative strand
RNA was approximately half of that of the positive strand
RNA (Figure 4b). As positive control, the same RT–PCR
fragment for the negative strand RNA was observed in cells
transfected with wild-type transcripts (Figure 4b, lanes 8 and
11). In the negative controls, total RNA extracted from cells
transfected with Y94A (Figure 4b, lane 2) and R76A
(Figure 4b, lane 5) was analyzed by PCR directly using the
primer set for the negative strand RNA. No corresponding
PCR fragment was detected from these samples, demonstrat-
ing that the detection of the negative strand RNA in cells
transfected with wild-type and mutant constructs by RT–
PCR is due to the replication of viral RNA. These results con-
ﬁrm that transcription of the negative strand RNA has taken
place in cells transfected with the mutant transcripts.
The transcription of negative strand RNA in cells electro-
porated with wild-type, R76A, Y92A and Y94A transcripts
was then quantitatively determined and compared by real
time RT–PCR at 24 and 48 h post-electroporation, respect-
ively. Compared to cells transfected with wild-type tran-
scripts, the relative amounts of negative strand RNA in
cells transfected with R76A, Y92A and Y94A were 48,
46 and 50%, respectively, at 24 h post-electroporation
(Figure 4c, lanes 1–4). These ﬁgures were dropped to 41,
45 and 23%, respectively, at 48 h post-electroporation
(Figure 4c, lanes 5–6). Taken together, these results demon-
strate that transcription of the negative strand RNA has taken
place in cells transfected with the mutant transcripts. As the
level of negative strand RNA was not increased in cells trans-
fected with the mutant transcripts over a time-course experi-
ment, it suggests that transcription of these RNA species may
Figure 3. Introduction of single amino acid mutations into the IBV genome
and recovery of infectious mutant viruses. Vero cells electroporated with the
in vitro synthesized transcripts derived from an in vitro assembled full-length
clone (rIBV+N), the full-length clone containing the R76A mutation
(R76A+N), the full-length clone containing the Y94A mutation (Y94A+N),
the full-length clone containing the Q74A mutation (Q74A+N) and the full-
length clone containing the Y92A mutation [Y92A+N(1) and (2)] together
with the N transcripts. The trans-effects of wild type and mutant N transcripts
on rescue of infectious viruses form the in vitro synthesized full-length IBV
transcripts were analyzed by electroporation of Vero cells with the in vitro
synthesized full-length IBV transcripts together with wild-type (rIBV+N),
R76A (rIBV+N-R76A) and Y94 (rIBV+N-Y94A) mutant N transcripts. Cells
electroporated with the full-length wild-type IBV transcripts without the
N-transcripts (rIBV-N) were included as a negative control. Images were
taken at 3 days post-electroporation.
Nucleic Acids Research, 2006, Vol. 34, No. 17 4821occur only in the initially transfected cells using the in vitro
transcripts as templates.
Genetic stability and growth properties of the
Q74A mutant virus
The growth properties of the Q74A mutant virus on Vero
cells were tested by analysis of plaque sizes and growth
curves of passage 3 mutant virus. Compared to cells infected
with wild-type recombinant virus (rIBV), slightly smaller
sized plaques were observed in cells infected with the
Q74A mutant virus (Figure 5a). Analysis of the growth
curves of wild-type and the mutant virus demonstrated that
the mutant virus grew slightly more slowly than the wild
type recombinant virus. When 10-fold more mutant virus
was used, 2- to 10-fold more mutant virus was produced at
8–24 h post-infection (Figure 5a). The titers of the mutant
virus dropped more rapidly than wild-type virus at 36 and
48 h post-infection (Figure 5a).
Further characterization of the mutant virus was subse-
quently carried out by analysis of the genomic and subge-
nomic RNA, and the expression of viral structural proteins
S and N. Northern blot analysis of cells infected with the
5th passage of rIBV and Q74A mutant viruses showed
that similar amounts of genomic and subgenomic RNAs
were detected (Figure 5b). Quantitative comparison of the
subgenomic RNA synthesis by densitometry analysis of the
bands shown in Figure 5b demonstrated that in cells infected
with Q74A mutant virus (p5), the relative amounts of mRNA
2, 3, 4, 5 and 6 are  98, 101, 121, 104, 106 and 101%,
respectively, of those in cells infected with rIBV. However,
Western blot analysis of cells infected with rIBV and Q74A
mutant virus showed that more S and N proteins were detected
in cells infected with wild-type virus (Figure 5c, lanes 1–14).
To conﬁrm if the Q74A mutation is genetically stable
during passage of the mutant virus in cells, viral RNA
was isolated from cells infected with passage 2 and 5 virus
and ampliﬁed by RT–PCR. Sequencing analysis showed
that the two mutated nucleotides (CA-GC) remained stable
(Figure 5d). Furthermore, no compensatory mutation was
found in other region of the N protein, conﬁrming that
Q74A mutant virus is stable in cell culture system.
DISCUSSION
The intrinsic RNA-binding activity of the nucleocapsid
protein of RNA viruses is essential for packaging the RNA
genome into a RNP complex. In previous structural studies
of the N protein from two coronaviruses, the N-terminal
domain was shown to be resistant to proteolysis and to fold
independently (14,15). It serves as a functional unit critical
Figure 4. Analysis of negative strand RNA replication and subgenomic RNA transcription in cells transfected with wild-type and mutant full-length transcripts.
(a) Detection of subgenomic RNA synthesis in cells electroporated with rIBV (lane 2), R76A (lanes 2–5), Y94A (lanes 6–8), Q74A (lane 9) and Y92A (lane 10)
mutant transcripts. Total RNA was prepared from Vero cells electroporated with in vitro synthesized full-length transcripts 3 days post-electroporation. Regions
corresponding to the 50-terminal 415 and 1010 nt of the subgenomic mRNA4 and 3, respectively, were amplified by RT–PCR and analyzed on 1.2% agarose gel.
Lane 1 shows DNA markers and numbers on the left indicate the length of DNA in bases. (b) Detection of positive and negative strand RNA synthesis in cells
electroporated with rIBV (lanes 8 and 11), Y94A (lanes 3 and 4), R76A (lanes 6 and 7) and Y92A (lanes 9 and 10) mutant transcripts. Total RNA was prepared
from Vero cells electroporated with in vitro synthesized full-length transcripts 3 days post-electroporation. Regions corresponding to 14931–15600 nt of the
positive (+) and negative ( ) sense IBV RNA were amplified by RT–PCR and analyzed on 1.2% agarose gel. The negative controls shown in lanes 2 and 5 are
PCR analysis of total RNAs extracted from cells transfected with Y94A (lane 2) and R76A (lane 5) using the primer set for negative strand RNA. Lane 1 shows
DNA markers. Numbers on the left indicate nucleotides in bases. (c) Quantitative analysis of the negative strand RNA in cells transfected with wild type (lanes 1
and 5), R76A (lanes 2 and 6), Y92A (lanes 3 and 7) and Y94A (lane 4 and 8) by real time RT-PCT at 24 (lane 1–4) and 48 (lanes 5–8) h post-electroporation. The
relative ratios of the negative strand RNA in cells transfected with the mutant transcripts to those in cells transfected with wild type transcripts are shown.
Numbers on the left indicate nucleotides in bases.
4822 Nucleic Acids Research, 2006, Vol. 34, No. 17for the RNA-binding activity of the protein (14). Based on
these structural results, the importance of individual residues
in RNA-binding was studied. Here we showed that Tyr-94 in
strand b3 binds to the RNA ligand. The positively charged
Arg-76 is located in the immediate vicinity of this aromatic
residue at the base of the extended ﬂexible hairpin loop,
within a cluster of positively charged residues. Thus, the
interaction between Arg-76 and Tyr-94 with RNA appears
to play a crucial role during virus assembly. Since no single
mutation could totally disrupt nucleic acid binding, other
aromatic or basic residues located close to these two residues
at the surface of the N-terminal domain are likely to contri-
bute to RNA binding by creating a broad surface that
makes contact with the genomic RNA. Using a simple
docking experiment, the RNA binding site seems capable
of accommodating up to 8–9 nt bases per N-terminal domain
monomer. The Arg-76 and Tyr-94 residues identiﬁed in this
paper thus provide more precise mapping of the location of
the RNA-binding site on the IBV N protein.
It is interesting to note that the main effect of these
mutations on viral life cycles was on subgenomic RNA trans-
cription. However, the replication of negative strand RNA is
nearly normal in cells transfected with these mutant cons-
tructs. Is it possible that these mutations will directly impair
an undeﬁned function of the N protein that is essential
for subgenomic RNA transcription? Two possibilities were
considered. First, the coronavirus N protein is directly
involved in subgenomic RNA replication. The MHV N
protein was shown to be involved in coronaviral RNA trans-
cription (4), but the underlying mechanism was unrevealed.
Alternatively, the observed phenotypic changes in sub-
genomic RNA replication caused by these mutations may
be due to a generally reduced viral replication rate and
infectivity. In fact, several other mutations that affect viral
Figure 5. Analysis of the growth properties of wild type and Q74A mutant virus. (a) Plague sizes and one-step growth curves of rIBV and Q74A mutant viruses.
Monolayers of Vero cells on a 6-well plate were infected with 100 ml of 1-, 10- and 100-fold diluted virus stock and cultured in the presence of 0.5%
carboxymethy cellulose at 37 C for 3 days. The cells were fixed and stained with 0.1% toluidine. To determine the one-step growth curves of wild-type
recombinant IBV and Q74A mutant viruses, Vero cells were infected with wild type and Q74A mutant viruses, and harvested at 0, 8, 12, 16, 24, 36 and 48 h post-
inoculation, respectively, and viral stocks were prepared by freezing/thawing of the cells three times. The viral titer was determined by plaque assay on Vero
cells. (b) Northern blot analysis of the genomic and subgenomic RNAs in cells infected with wild type and Q74A mutant viruses. Ten micrograms of total RNA
extracted from Vero cells infected with rIBV and Q74A mutant viruses (passage 3 and 5), respectively, were separated on 1% agarose gel and transferred to a
Hybond N+ membrane. Viral RNAs were probed with a Dig-labelled DNA probe corresponding to the 3-end 680 nt of the IBV genome. Total RNA extracted
from mock-infected cells was included as negative control. Numbers on the left indicate nucleotides in kilobase and numbers on the right indicate the genomic
and subgenomic RNA species of IBV. (c) Western blot analysis of viral protein expression in cells infected with wild type and Q74A mutant viruses. Vero cells
infected with wild type recombinant IBV (lanes 1–7) and Q74A mutant virus (lanes 8–14) were harvested at 0, 8, 16, 24, 36 and 48 h postinfection, respectively,
lysates prepared and separated on SDS-10% polyacrylamide gel. The expression of S and N proteins was analyzed by western blot with polyclonal anti-S and
anti-N antibodies, respectively. The same membrane was also probed with anti-actin antibody as a loading control. Numbers on the left indicate molecular
masses in kilodaltons. (d) Nucleotide sequencing of Q74A mutant virus. Total RNA was prepared from Vero cells infected with passage 5 of the Q74A mutant
virus and the region covering the Q74A (CAA!GCA) mutation was amplified by RT–PCR and sequenced by automated nucleotide sequencing. A 30 nt region
flanking the CAA!GCA mutation is shown.
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RNA transcription (25–27). In this study, we have repeatedly
observed that detection of subgenomic RNA replication
in cells infected with low multiplicity of infectivity of IBV
by RT–PCR is technically challenging. Positive results
can be obtained only if transcription of subgenomic RNA
reaches a certainly high level. When in vitro transcripts con-
taining Y92A mutation were introduced into cells, one or two
CPEs were always observable in a monolayer, suggesting
the presence of low level viral RNA replication. However,
detection of subgenomic RNA was consistently unsuccessful
in cells electroporated with this mutant transcript.
Coronavirus N protein is a multi-functional protein. The
protein was shown to be able to facilitate rescue of infectious
virus from several coronaviruses by co-electroporation of the
in vitro synthesized N transcripts with the in vitro synthesized
full-length transcripts (17,28–30). The mechanism for this
trans-effect is currently unknown. In this study, the R76A
and Y94A mutant N constructs could promote rescue of the
infectivity of the in vitro synthesized IBV RNA as efﬁciently
as did the wild type N transcripts, suggesting that the reduced
RNA-binding activity in the N-terminal domain does not
affect this function of the N protein. It also suggests that
RNA-binding per se is not a major factor that contributes
to this important function of the N protein.
Are the reduced replication rate and loss of the infectivity
of the mutant transcripts caused by the effects of these muta-
tions on the functionality of the N protein or on the integrity
of the genomic RNA itself? The nice correlation between the
reduced RNA-binding activity of the N-terminal domain from
the mutant proteins and the loss of infectivity of the corres-
ponding mutant transcripts would support that the failure to
rescue the viral infectivity is due to the speciﬁc mutation
that impairs the functionality of the N protein. In addition,
in the cases of Q74A and R76A mutants, the two mutations
are physically adjacent in the genome, but yet totally different
phenotypes were observed from the two mutants. It would
support that the failure to recover infectious viruses from
the mutant transcripts is due to the fact that these mutations
reduce/impair the RNA-binding activity of the N protein.
If this were the case, however, supplement of wild type N
protein in trans would rescue the infectivity of the mutant
transcripts. Two experiments were conducted to test this
possibility, but none of them were successful. First,
co-transfection of the mutant full-length transcripts with
wild-type N transcripts into cells failed to recover infectious
virus from the mutant transcripts, suggesting that wild-type N
RNA cannot rescue the infectivity of the mutant transcripts
in trans. The second experiment was to introduce the
mutant full-length transcripts into cells stably expressing a
six-His-tagged IBV N protein. Once again, it failed to rescue
the infectivity of the mutant transcripts. At present, it is
unclear if this was due to the low-level expression of N
protein in these cells or because the N protein expressed in
these cells contains the six-His tag at its C-terminus.
Residues Arg-76 and Tyr-94 in the IBV N protein are well
conserved across the whole family of coronaviruses. Structur-
ally, these two residues may correspond to the Arg-94 and
Tyr-112 residues in the SARS-CoV N protein (see Figure 1a).
It is possible that introduction of similar alanine mutations
into the SARS-CoV genome may yield a similar phenotype
observed here for IBV. The fact that substitutions of
Gln-74, Arg-76, Tyr-72 and Tyr-94 in the IBV genome by
using an infectious clone of IBV showed nice correlation
between the RNA-binding activity and viral infectivity
would suggest potential strategies for intervention of viral
replication. A compound which could speciﬁcally bind to
this region of the N protein might interfere with RNA binding
and thus inhibit virus replication. In addition, this study
points to a number of residues on the surface of the N protein
that contribute less to the RNA-binding activity and viral
infectivity for the design of attenuated coronavirus strains
as potential vaccine candidates.
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